The big fat bariatric bandwagon J. H. PinkneyA. B. JohnsonE. A. M. Gale Editorial 10 July 2010 Pages: 1815 - 1822
Glucose-lowering therapies and cancer risk: the trials and tribulations of trials and observations J. A. JohnsonY. Yasui Commentary 04 June 2010 Pages: 1823 - 1826
The glucagon-producing alpha cell: an electrophysiologically exceptional cell M. BraunP. Rorsman Commentary 16 June 2010 Pages: 1827 - 1830
Tribbles homologue 3 (TRIB3) and the insulin-resistance genes in type 2 diabetes F. Beguinot Commentary 22 June 2010 Pages: 1831 - 1834
Prime time for DIAMAP: a road map for diabetes research in Europe P. A. Halban Commentary 08 May 2010 Pages: 1835 - 1837
Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials P. D. HomeS. E. Kahnfor the ADOPT Study Group and the RECORD Steering Committee Article Open access 08 June 2010 Pages: 1838 - 1845
Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes M.-R. TaskinenP. J. Barteron behalf of the FIELD study investigators Article 06 June 2010 Pages: 1846 - 1855
Autonomic neuropathy predisposes to rosiglitazone-induced vascular leakage in insulin-treated patients with type 2 diabetes: a randomised, controlled trial on thiazolidinedione-induced vascular leakage A. J. RenningsP. SmitsC. J. Tack Article Open access 25 May 2010 Pages: 1856 - 1866
Diabetes, prediabetes and cancer mortality X. H. ZhouQ. Qiaofor the DECODE Study Group Article 21 May 2010 Pages: 1867 - 1876
Low-intensity physical activity is associated with reduced risk of incident type 2 diabetes in older adults: evidence from the English Longitudinal Study of Ageing P. DemakakosM. HamerA. Steptoe Article 22 May 2010 Pages: 1877 - 1885
Proteinuria modifies the effects of physical activity on total and cardiovascular disease mortality rates in patients with type 2 diabetes T. VepsäläinenM. SoinioT. Rönnemaa Short Communication 06 June 2010 Pages: 1886 - 1889
Recent population changes in HbA1c and fasting insulin concentrations among US adults with preserved glucose homeostasis Y. J. ChengH. S. KahnL. S. Geiss Short Communication 27 May 2010 Pages: 1890 - 1893
Homeostasis model assessment of insulin resistance and the risk of cardiovascular events in middle-aged non-diabetic Japanese men K. NakamuraM. SakuraiH. Nakagawa Article 26 May 2010 Pages: 1894 - 1902
DDOST, PRKCSH and LGALS3, which encode AGE-receptors 1, 2 and 3, respectively, are not associated with diabetic nephropathy in type 1 diabetes A. HoverfeltR. Sallinenon behalf of the FinnDiane Study Group Short Communication 21 May 2010 Pages: 1903 - 1907
Type 2 diabetes risk alleles near ADCY5, CDKAL1 and HHEX-IDE are associated with reduced birthweight E. A. AnderssonK. PilgaardO. Pedersen Article 20 May 2010 Pages: 1908 - 1916
Voltage-dependent K+ channels are positive regulators of alpha cell action potential generation and glucagon secretion in mice and humans A. F. SpigelmanX. DaiP. E. MacDonald Article 06 May 2010 Pages: 1917 - 1926
ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors in mice S. AmistenS. Meidute-AbaravicieneD. Erlinge Article 06 June 2010 Pages: 1927 - 1934
The suppressor of cytokine signalling 2 (SOCS2) is a key repressor of insulin secretion P. LebrunE. CognardE. Van Obberghen Article 25 May 2010 Pages: 1935 - 1946
Subplasmalemmal Ca2+ measurements in mouse pancreatic beta cells support the existence of an amplifying effect of glucose on insulin secretion M. A. RavierR. Cheng-XueP. Gilon Article 13 May 2010 Pages: 1947 - 1957
Subcutaneous insulin B:9-23/IFA immunisation induces Tregs that control late-stage prediabetes in NOD mice through IL-10 and IFNγ G. FousteriA. DaveM. von Herrath Article Open access 20 May 2010 Pages: 1958 - 1970
Aberrant hepatic TRIB3 gene expression in insulin-resistant obese humans H. OberkoflerA. PfeifenbergerW. Patsch Short Communication 13 May 2010 Pages: 1971 - 1975
Effect of physical training on mitochondrial respiration and reactive oxygen species release in skeletal muscle in patients with obesity and type 2 diabetes M. Hey-MogensenK. HøjlundK. Sahlin Article 06 June 2010 Pages: 1976 - 1985
Naturally occurring R225W mutation of the gene encoding AMP-activated protein kinase (AMPK)γ3 results in increased oxidative capacity and glucose uptake in human primary myotubes S. A. CrawfordS. R. CostfordM.-E. Harper Article 15 May 2010 Pages: 1986 - 1997
Differential aetiology and impact of phosphoinositide 3-kinase (PI3K) and Akt signalling in skeletal muscle on in vivo insulin action M. FriedrichsenP. PoulsenJ. F. P. Wojtaszewski Article 29 May 2010 Pages: 1998 - 2007
Increased levels of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC-1α) improve lipid utilisation, insulin signalling and glucose transport in skeletal muscle of lean and insulin-resistant obese Zucker rats C. R. BentonG. P. HollowayA. Bonen Article 20 May 2010 Pages: 2008 - 2019
Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetes A. WillcoxS. J. RichardsonN. G. Morgan Article 09 June 2010 Pages: 2020 - 2028
Capillary pressure may predict preclinical changes in the eye K. M. GoodingJ. E. TookeA. C. Shore Article Open access 06 June 2010 Pages: 2029 - 2035
QT interval prolongation during spontaneous episodes of hypoglycaemia in type 1 diabetes: the impact of heart rate correction T. F. ChristensenL. TarnowO. K. Hejlesen Article 23 May 2010 Pages: 2036 - 2041
Retinal fractal dimension is increased in persons with diabetes but not impaired glucose metabolism: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study J. W. Y. YauR. KawasakiT. Y. Wong Short Communication 05 June 2010 Pages: 2042 - 2045
Transgenic mice overproducing human thioredoxin-1, an antioxidative and anti-apoptotic protein, prevents diabetic embryopathy Y. KamimotoT. SugiyamaN. Sagawa Article 29 May 2010 Pages: 2046 - 2055
Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats A. KuwabaraM. SatohN. Kashihara Article Open access 06 June 2010 Pages: 2056 - 2065
Nocturnal hypoglycaemia presenting as somnambulism D. S. H. Bell Research Letter 29 June 2010 Pages: 2066 - 2067
Regulation of oxidative stress and inflammation by glycaemic control: evidence for reversible activation of the 5-lipoxygenase pathway in type 1, but not in type 2 diabetes R. BoizelG. BruttmannF. Stanke-Labesque Research Letter 10 June 2010 Pages: 2068 - 2070
Diabetes, cancer and iron L. MascitelliF. PezzettaM. R. Goldstein Letter 23 June 2010 Pages: 2071 - 2072
Wingless-type MMTV integration site family (WNT) signalling in pancreatic beta cells—more complex than expected S. Schinner Letter 06 June 2010 Pages: 2073 - 2075
Should the algorithm for the treatment of type 2 diabetes be evidence-based? P.-J. Guillausseau Letter 07 July 2010 Pages: 2076 - 2077
Erratum to: Consensus guidelines, algorithms and care of the individual patient with type 2 diabetes J. J. Nolan Erratum 08 June 2010 Pages: 2078 - 2078